Xatral LP 5mg (Alfuzosin) 56 tablets in Kenya

XATRAL LP 5MG, supplied as 56 prolonged-release tablets, contains Alfuzosin as its active ingredient. Alfuzosin is a pharmaceutical drug belonging to the alpha-1 blocker class. As an antagonist of the alpha-1 adrenergic receptor, it functions by relaxing the muscles in the prostate and bladder neck. Consequently, this action makes it easier for men to urinate. The “LP” (Long-Acting or Prolonged-Release) designation indicates that this formulation releases the medication gradually over time, allowing for a sustained effect. Xatral LP 5mg is a prescription-only medication primarily used to manage symptoms associated with Benign Prostatic Hyperplasia (BPH).

Unpacking the Formulation: Key Component and its Mechanism

Alfuzosin’s mechanism specifically targets the muscular components of the lower urinary tract to alleviate BPH symptoms effectively.

• Alfuzosin (5mg):
  • Class: Alpha-1 Adrenergic Receptor Blocker.
  • Mechanism of Action: Alfuzosin selectively blocks alpha-1 adrenergic receptors, which are found predominantly in the smooth muscles of the prostate, bladder neck, and prostatic urethra. The activation of these receptors typically causes muscle contraction, which obstructs urine flow in men with an enlarged prostate. By blocking these receptors, alfuzosin induces relaxation of the smooth muscles in these critical areas. This relaxation, in turn, reduces the dynamic obstruction to urine outflow from the bladder, thereby improving urinary flow and alleviating the bothersome lower urinary tract symptoms (LUTS) associated with BPH. Alfuzosin exhibits functional uroselectivity, meaning it preferentially acts on the lower urinary tract with less impact on systemic blood pressure compared to non-selective alpha-blockers. However, patients should still be aware of the risk of postural hypotension. The prolonged-release (LP) formulation ensures a gradual and sustained release of Alfuzosin, which contributes to its once or twice-daily dosing regimen and helps maintain consistent therapeutic levels while potentially reducing peak-related side effects.

Addressing Health Concerns and User Needs

XATRAL LP 5mg directly addresses the functional symptoms of benign prostatic hyperplasia (BPH) in men, providing symptomatic relief.

• Benign Prostatic Hyperplasia (BPH) Symptoms: It targets common BPH symptoms such as:
  • Difficulty initiating urination (hesitancy).
  • Weak or interrupted urinary stream.
  • Feeling of incomplete bladder emptying.
  • Frequent urination, especially at night (nocturia).
  • Urgent need to urinate.
• Improved Urinary Flow: By relaxing the muscles, it facilitates easier passage of urine, leading to a stronger stream and more complete bladder emptying.
• Enhanced Quality of Life: By alleviating these bothersome urinary symptoms, it significantly improves the daily comfort and quality of life for men living with BPH.
• Flexible Dosing: The 5mg prolonged-release dose may be used as an initial dose in certain patient populations (e.g., elderly, those with kidney impairment) or as a maintenance dose, sometimes twice daily, based on individual response and tolerability.

Identifying Indications for Use

XATRAL LP 5mg is a prescription-only medication specifically indicated for:

• Treatment of the functional symptoms of benign prostatic hypertrophy (BPH) in adult men.
• It is often used as a starting dose or a maintenance dose for symptom control in BPH, particularly when a doctor determines a need for a dose between 2.5mg multiple times daily and 10mg once daily.

Primary Uses

The primary uses of XATRAL LP 5mg include:

• Alleviating obstructive and irritative urinary symptoms caused by an enlarged prostate.
• Facilitating urination by relaxing bladder neck and prostatic muscles.
• Supporting bladder emptying and reducing post-void residual volume.
• Providing a controlled-release formulation for consistent symptom management in BPH.

Understanding Potential Side Effects and Critical Precautions

As an alpha-1 blocker, Alfuzosin can cause certain side effects, primarily related to its effect on blood pressure.

Common Side Effects

• Dizziness or Lightheadedness: This is particularly common, especially when standing up quickly from a sitting or lying position (orthostatic hypotension). It is more prevalent at the start of treatment or after a dose increase.
• Headache.
• Fatigue or Weakness (Asthenia).
• Nausea.
• Abdominal pain.
• Dry mouth.
• Sweating or Flushes.
• Runny or stuffy nose (Rhinitis).

Less Common but More Serious Side Effects (Requiring Immediate Medical Attention)

• Fainting (Syncope): A sudden, temporary loss of consciousness due to a drop in blood pressure.
• Chest Pain (Angina Pectoris): While uncommon, it can occur or worsen in patients with pre-existing coronary artery disease. If this happens, stop the medication and seek urgent medical help.
• Irregular Heartbeat or Palpitations (Tachycardia, Atrial Fibrillation).
• Priapism: A prolonged, painful erection of the penis, unrelated to sexual activity, that does not go away. This is a rare but serious emergency requiring immediate medical attention to prevent permanent damage.
• Allergic Reactions: Symptoms like rash, itching, hives, swelling of the face, lips, tongue, or throat, or difficulty breathing (angioedema).
• Liver Problems: Signs include yellowing of the skin or eyes (jaundice), dark urine, persistent nausea/vomiting, severe stomach pain.
• Intraoperative Floppy Iris Syndrome (IFIS): A complication that can occur during cataract surgery, where the iris becomes floppy. Inform your eye surgeon if you are taking or have taken Alfuzosin.

Critical Safety Warnings and Precautions for Xatral LP 5mg

Xatral LP 5mg is a prescription-only medication. Its use MUST be under the strict guidance and supervision of a qualified physician.

Orthostatic Hypotension and Cardiac Risks

• Orthostatic Hypotension/Fainting: Patients must be advised to rise slowly from a sitting or lying position to minimize dizziness or fainting. If dizziness or lightheadedness occurs, they should sit or lie down immediately. This risk is higher at the start of treatment or after a dose increase.
• Cardiac Conditions:
  • Angina: If you have coronary artery disease or a history of angina, Xatral LP should be used with caution. If angina symptoms recur or worsen, discontinue alfuzosin and seek medical advice.
  • QT Prolongation: Use with caution in patients with known or suspected congenital or acquired QT prolongation, or those taking medications that prolong the QT interval.
  • Heart Failure: Caution is advised in patients with acute cardiac failure.

Liver and Kidney Considerations

• Liver Impairment: Xatral LP is contraindicated in patients with moderate to severe liver impairment. Use with caution in mild liver impairment; a lower initial dose or reduced frequency may be necessary.
• Kidney Impairment: Use with caution in severe kidney impairment (creatinine clearance < 30 mL/min). A lower initial dose may be necessary.

Drug Interactions and Other Warnings

• Concomitant Medications: Inform your doctor about all other medications (prescription, over-the-counter, and herbal supplements), especially:

  • Other Alpha-1 Blockers: Do not use Xatral LP with other alpha-1 adrenergic receptor blockers (e.g., prazosin, doxazosin, tamsulosin, silodosin) due to the increased risk of severe hypotension.

  • Antihypertensive Medications: Concomitant use with blood pressure-lowering drugs (e.g., ACE inhibitors, beta-blockers, diuretics) can enhance the hypotensive effect of alfuzosin, leading to increased risk of dizziness or fainting.

  • PDE5 Inhibitors: Drugs for erectile dysfunction or pulmonary hypertension (e.g., sildenafil, tadalafil, vardenafil) can significantly lower blood pressure when taken with alfuzosin. Use with extreme caution, often starting with the lowest dose of the PDE5 inhibitor.

  • Strong CYP3A4 Inhibitors: Certain medications (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin) can significantly increase alfuzosin levels in the blood, leading to increased side effects. Concomitant use with some of these (e.g., ritonavir) is contraindicated.
• Cataract Surgery: Advise your eye surgeon that you are taking or have taken Xatral LP/Alfuzosin before any cataract or glaucoma surgery due to the risk of Intraoperative Floppy Iris Syndrome (IFIS).
• Priapism: Seek immediate medical attention for any prolonged, painful erection.
• Not for Women or Children: Xatral LP is indicated only for men. It is not for use in women (especially pregnant or breastfeeding) or children.
• Prostate Cancer Exclusion: BPH and prostate cancer can have similar symptoms. Your doctor should exclude prostate cancer before initiating treatment with Xatral LP.
• Swallow Whole: Patients must swallow the tablet whole. Do not crush, chew, or split the tablet, as this can lead to rapid release and increased side effects.

Recommended Dosage and Administration Guidelines

• Dosage: The recommended dose for Xatral LP 5mg (prolonged-release) is typically one 5mg tablet twice daily, usually in the morning and evening. For elderly patients (over 65 years) or those with impaired kidney function, an initial dose of one 5mg tablet once daily may be prescribed. The dose may be increased to 10 mg daily (as 5mg twice daily or 10mg once daily) if well tolerated and a stronger effect is required.
  • Always follow your doctor’s exact prescription and instructions. Do not modify your dose or duration of treatment without consulting your doctor.
• Administration:
  • Take the tablet orally, immediately after a meal. Taking it after a meal improves absorption and reduces the risk of side effects.
  • Swallow the prolonged-release tablet whole with a glass of water. Do not crush, chew, or split the tablet, as this can lead to rapid and excessive release of the active ingredient, increasing the risk of adverse effects.
  • Take it at approximately the same time each day to maintain consistent drug levels.
• Missed Dose: If you miss a dose, do not take a double dose to compensate. Take your next dose at the regularly scheduled time and continue with your routine.
• Duration: Follow your doctor’s prescribed duration of treatment. It is generally a long-term treatment for BPH symptoms.

Price in Kenya (Approximate)

As of Tuesday, July 1, 2025, the approximate price for XATRAL LP 5MG (ALFUZOSIN 5MG) – 56 TABS in Kenya can range from Ksh 3,500 to Ksh 6,500 per pack.

Note: Prices can vary significantly between different pharmacies, hospitals, and medical suppliers in Kenya. These variations depend on factors such as import costs, specific pharmacy markups, and stock availability. It is advisable to check with specific vendors for the most current pricing.

Conclusion

XATRAL LP 5mg (Alfuzosin) provides effective and sustained symptomatic relief for men experiencing Benign Prostatic Hyperplasia (BPH) in Kenya. As an alpha-1 blocker, it helps relax muscles in the prostate and bladder neck, consequently facilitating easier urination. This prolonged-release formulation offers the convenience of once or twice-daily dosing while ensuring consistent therapeutic levels. However, users must adhere strictly to the prescribed dosage and administration guidelines, particularly taking it after a meal and swallowing it whole. Furthermore, due to potential side effects like dizziness and serious interactions with other medications, Xatral LP 5mg requires a prescription and close medical supervision. Patients should always inform their doctor about all existing medical conditions and other medications to ensure safe and effective treatment.